Childhood immunisation statistics Scotland
Quarter and year ending 30 September 2021

About this release

This release by Public Health Scotland provides a quarterly update of immunisation uptake rates for children in Scotland at 12 months, 24 months, five years and six years of age. Immunisation programmes for children aim to protect the individual child from many serious infectious diseases and prevent the spread of disease in the wider population.

Main points                      

• Uptake rates remained high in Scotland; over 96% of children had received each routine immunisation by the time they were 12 months old, with the exception of rotavirus vaccine, which had 94.1% uptake.

Chart showing uptake of the routine vaccines given at 12 months old, by quarter, from quarter ending December 2017 to quarter ending September 2021. Uptake of all routine immunisations has remained high over time (above 95%), with the exception of rotavirus, which must be given within a very short time window and has slightly lower uptake compared with the other routine vaccines.

Close

Primary immunisation uptake rates by 12 months old, by quarter

Note: Children turning 12 months old in the relevant quarter, e.g. for January to March 2019 this would be children born during January to March 2018.

• The vast majority of children received their booster vaccines by 24 months of age: Hib/MenC (94.9%), Pneumococcal Conjugate Vaccine (PCV) (94.9%), MenB (94.4%).
• The first dose of MMR vaccine is offered between 12 and 13 months old and the second dose at 3 years 4 months old. Although normally given at these times, it can be given at any age if missed.
• 94.4% of children had the first dose of MMR vaccine by 24 months of age. This rose to 96.6% for children who reached age five.
• Uptake of the second dose of MMR vaccine by five years was 92.8%, rising to 93.8% by age six years.

Background

As a public health measure, immunisations are very effective in reducing the burden of disease. The European Region of the World Health Organization (WHO) recommends that on a national basis at least 95% of children are immunised against diseases preventable by immunisation and targeted for elimination or control. These include diphtheria, tetanus, pertussis, polio, Haemophilus influenzae type b (Hib), measles, mumps and rubella.

Rotavirus vaccine helps to protect young children from infection that causes severe diarrhoea and vomiting. This vaccine should be given within strict age limits, with the first dose before 15 weeks and second dose before 24 weeks of age. These age limits mean that if a child is not immunised with the first dose early enough, due to missed appointments for example, then it may not be possible for them to complete the full two dose course before 24 weeks. This explains why uptake of the completed two dose course of rotavirus vaccine is slightly lower than completed courses of the other vaccines offered in the first year of life.

Information on uptake among pre-school children eligible for immunisation during the coronavirus (COVID-19) pandemic is available on our COVID-19 wider impacts on the healthcare system dashboard and shows that uptake has remained high.

Further information

The next release of this publication will be in March 2022.